诊疗指南

2016 ACIP 美国成人免疫接种程序指南

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2016.
2016-03-01 11:10 点击次数:558发表评论

Changes in the 2016 adult immunization schedule from the 2015 schedule included the following new ACIP recommendations:

•Interval change for 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) from “6 to 12 months” to “at least 1 year” for adults aged ≥65 years who do not have immunocompromising conditions, anatomical or functional asplenia, cerebrospinal fluid leaks, or cochlear implants (1). The interval for adults aged ≥19 years with any of these conditions is at least 8 weeks (2).

•Serogroup B meningococcal (MenB) vaccine series should be administered to certain groups of persons aged ≥10 years who are at increased risk for serogroup B meningococcal disease (3).

•Men B vaccine series may be administered to adolescents and young adults aged 16 through 23 years (preferred age is 16 through 18 years) to provide short-term protection against most strains of serogroup B meningococcal disease (4).

•Nine-valent human papillomavirus (HPV) vaccine (9vHPV) has been added to the schedule and can be used for routine vaccination of females and males against HPV (5).

    
学科代码:内科学   关键词:美国 成人免疫接种程序 ,指南 爱思唯尔医学网, Elseviermed
顶一下(0
您可能感兴趣的指南
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录